Ranibizumab for high-risk proliferative diabetic retinopathy. An exploratory randomized controlled trial

Figueira J.; Silva R.; Henriques J.; Rosa P.C.; Nunes S.; Cunha-Vaz J.

Ophthalmologica. 2016;235(1):34-41. doi: 10.1159/000442026.

2015